Rachel Badovinac, DMD, ScD

Instructor in Developmental Biology
Harvard School of Dental Medicine

Phone: (617) 525-4479
Email: rachel_badovinac@hsdm.harvard.edu


ScD in Epidemiology, Harvard School of Public Health, 2006

ScM in Epidemiology, Harvard School of Public Health, 2000

DMD, Harvard School of Dental Medicine, 1999 

BA in International Studies, Johns Hopkins University, 1994


Multigenic Dissection of Non-syndromic Oral Clefts: identification of the specific genetic bases of oral clefts that do not occurr as part of known syndromes.

The Anomalome: comprehensive atlas of network of co-occurence and interaction among congenital anomalies.

Founding Director, K-Award ClubHarvard Medical School.Member, Commission for on Change and InnovationAmerican Dental Education Association.Member, Committee on Human Studies(IRB), Harvard Medical School.
Selected publications
  1. Kim DM, Badovinac RL, Lorenz RL, Fiorellini JP, Weber HP. A 10-year prospective clinical and radiographic study of one-stage dental implants. Clinical Oral Implants Research, in press.Kim DM, Koszeghy KL, Badovinac RL, Kawai T, Hosokawa I, Howell TH, Karimbux TH. Aspirin’s effect on gingival crevicular fluid levels of inflammatory and anti-inflammatory mediators in gingivitis patients. J Periodontol, in press.Badovinac RL, Werler MM, Williams PL, Kelsey KT, Hayes C. Folate-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol. 2007; 79:8-15.
  2. Badovinac RL, Morgan KE, Lefevre J, Wadhawan S, Mucci L, Schoeff L, Douglass CW. Risk assessment criteria applied to a screening exam: implications for improving the efficiency of a sealant program. J Public Health Dent. 2005 Fall;65(4):203-8.

  3. Badovinac R, Douglass C. Biostatistics. In Mason J, editor. Concepts in Dental Public Health. Baltimore, MD: Lippincott Williams and Wilkins, 2005.

  4. Hernandez-Diaz S, Wu XF, Hayes C, Werler MM, Ashok TD, Badovinac R, Kelsey KT, Mitchell AA. Methylenetetrahydrofolate reductase polymorphisms and the risk of gestational hypertension. Epidemiology. 2005 Sep;16(5):628-34.

  5. Royzman D, Recio L, Badovinac RL, Fiorellini J, Goodson M, Howell H, Karimbux N. The effect of aspirin intake on bleeding on probing in patients with gingivitis.J Periodontol. 2004 May;75(5):679-84.

  6. Donley CL, Badovinac R, Sapir S, Shapira L, Houri Y, Kantarci A, Warbington ML, Dibart S, Van Dyke TE, Needleman HL, Karimbux N, Bimstein E. IgG antibody levels to Porphyromonas gingivalis and clinical measures in children. J Periodontol. 2004 Feb;75(2):221-8

  7. Bochner D, Badovinac RL, Howell TH, Karimbux NY. Tutoring in a problem-based curriculum: expert versus nonexpert. J Dent Educ. 2002 Nov;66(11):1246-51.

  8. Cruikshank D, Howell TH, Brinckerhoff LC, Badovinac R, Karimbux NY. Learning disabilities in dental education: trends, management, and concerns in U.S. dental schools. J Dent Educ. 2002 Oct;66(10):1178-84.

  9. Badovinac R, Hayes C, Monopoli M. Smokeless tobacco and oral cancer. J Mass Dent Soc. 2001 Spring;50(1):26-9, 47.

  10. Adra CN, Donato JL, Badovinac R, Syed F, Kheraj R, Cai H, Moran C, Kolker MT, Turner H, Weremowicz S, Shirakawa T, Morton CC, Schnipper LE, Drews R. SMARCAD1, a novel human helicase family-defining member associated with genetic instability: cloning, expression, and mapping to 4q22-q23, a band rich in breakpoints and deletion mutants involved in several human diseases. Genomics. 2000 Oct 15;69(2):162-73.

  11. Niederman R, Badovinac R. Tradition-based dental care and evidence-based dental care.
    J Dent Res. 1999 Jul;78(7):1288-91.

  12. Niederman R, Ferguson M, Urdaneta R, Badovinac R, Christie D, Tantraphol M, Rasool F. Evidence-based esthetic dentistry. J Esthet Dent. 1998;10(5):229-34.